Breast cancer treatment disparities in patients with severe mental illness: A systematic review and meta‐analysis
Psycho-Oncology · 2023-05 · 32 (5) · 651-662
DOI: 10.1002/pon.6120 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Psycho-Oncology, online erschienen am 14.03.2023. Verfasst von Steve Kisely und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Queensland, School of Clinical Medicine, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Breast Neoplasms, Mental Disorders. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
The incidence and mortality rates of breast cancer in individuals with pre‐existing severe mental illness (SMI), such as schizophrenia, bipolar disorder, and major depression, are higher than in the general population. Reduced screening is one factor but there is less information on possible barriers to subsequent treatment following diagnosis.
Methods
We undertook a systematic review and meta‐analysis on access to guideline‐appropriate care following a diagnosis of breast cancer in people with SMI including the receipt of surgery, endocrine, chemo‐ or radiotherapy. We searched for full‐text articles indexed by PubMed, EMBASE, PsycInfo and CINAHL that compared breast cancer treatment in those with and without pre‐existing SMI. Study designs included population‐based cohort or case‐control studies.
Results
There were 13 studies included in the review, of which 4 contributed adjusted outcomes to the meta‐analyses. People with SMI had a reduced likelihood of guideline‐appropriate care (RR = 0.83, 95% CI = 0.77–0.90). Meta‐analyses were not possible for the other outcomes but in adjusted results from a single study, people with SMI had longer wait‐times to receiving guideline‐appropriate care. The results for specific outcomes such as surgery, hormone, radio‐ or chemotherapy were mixed, possibly because results were largely unadjusted for age, comorbidities, or cancer stage.
Conclusions
People with SMI receive less and/or delayed guideline‐appropriate care for breast cancer than the general population. The reasons for this disparity warrant further investigation, as does the extent to which differences in treatment access or quality contribute to excess breast cancer mortality in people with SMI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Queensland, School of Clinical Medicine, Brisbane, Queensland, Australia.
- Metro South Addiction and Mental Health Service, Brisbane, Queensland, Australia.
- Departments of Psychiatry, Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.
- University of Queensland, School of Public Health, Brisbane, Queensland, Australia.
ORCID-Profile: Steve Kisely, Meshary Khaled N Alotiby
Zitieren
APA
Kisely, S., Alotiby, M. K. N., Protani, M. M., Soole, R., Arnautovska, U., & Siskind, D. (2023). Breast cancer treatment disparities in patients with severe mental illness: A systematic review and meta‐analysis. Psycho-Oncology, 32(5), 651-662. https://doi.org/10.1002/pon.6120
Vancouver
Kisely S, Alotiby MKN, Protani MM, Soole R, Arnautovska U, Siskind D. Breast cancer treatment disparities in patients with severe mental illness: A systematic review and meta‐analysis. Psycho-Oncology. 2023;32(5):651-662. doi:10.1002/pon.6120
BibTeX
@article{Kisely2023,
author = {Kisely, Steve and Alotiby, Meshary Khaled N and Protani, Melinda M and Soole, Rebecca and Arnautovska, Urska and Siskind, Dan},
title = {Breast cancer treatment disparities in patients with severe mental illness: A systematic review and meta‐analysis},
journal = {Psycho-Oncology},
year = {2023},
volume = {32},
number = {5},
pages = {651--662},
doi = {10.1002/pon.6120}
}
EUVIMED